The World Health Organization announced that a batch of contaminated cough syrup produced in India has been found in the Marshall Islands and Micronesia. Foreign media reports that according to a WHO inspection, tested samples of Guaifenesin TG syrup, made by Punjab-based QP Pharmachem Ltd, showed "unacceptable levels of diethylene glycol and ethylene glycol".
The check shows that both components of the syrup are toxic to humans and can be fatal if consumed. The WHO statement said the product, which is used to relieve chest congestion and cough symptoms, had been tested by Australia's drug regulator, the Therapeutic Goods Administration, but did not specify whether anyone had any side effects from using the syrup.
The latest warning comes months after the WHO linked the deaths of 69 children late last year to the use of Indian-made syrups. In Uzbekistan, the deaths of at least 19 children last year were linked to a cough syrup made in India. The syrup, Doc-1 Max, was found by Uzbekistan's health ministry to contain ethylene glycol. The Indian manufacturer of Doc-1 Max was ordered to stop production of the syrup after the deaths.
Sudhir Pathak, managing director of QP Pharmachem, said the company had exported a batch of 18,346 bottles to Cambodia after receiving all necessary regulatory approvals. He said he did not know how the product reached the Marshall Islands and Micronesia.
India is the world's largest exporter of generic drugs, meeting most of the medical needs of developing countries.